These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1392733)
1. Restricted entry to the tamoxifen trial. Rees DA BMJ; 1992 Mar; 304(6830):844. PubMed ID: 1392733 [No Abstract] [Full Text] [Related]
2. Tamoxifen and liver cancer. Hard GC; Williams GM; Iatropoulos MJ Lancet; 1993 Aug; 342(8868):444-5. PubMed ID: 8101953 [No Abstract] [Full Text] [Related]
3. Tamoxifen for the prevention of breast cancer: no. DeGregorio MW; Maenpaa JU; Wiebe VJ Important Adv Oncol; 1995; ():175-85. PubMed ID: 7672804 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen and breast cancer prevention: are we aware of the risks? Mandeville R; Houde M Cancer Prev Control; 1997; 1(1):66-72. PubMed ID: 9765729 [No Abstract] [Full Text] [Related]
5. [Prevention of breast cancer by tamoxifen. The opinion of the French Society of Senology and Breast Pathology]. Rev Fr Gynecol Obstet; 1994 Nov; 89(11):578-9. PubMed ID: 7817089 [No Abstract] [Full Text] [Related]
6. Tamoxifen--breast cancer preventive or human carcinogen? Clute E Toxicol Ind Health; 1995; 11(5):503-10. PubMed ID: 8677515 [TBL] [Abstract][Full Text] [Related]
7. Correspondence re: R. R. Love, The National Surgical Adjuvant Breast Project (NSABP) Breast Cancer Prevention Trial revisited. Cancer Epidemiol., Biomarkers & Prev., 2: 403-407, 1993. Williams GM; Hard GC Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):185-6. PubMed ID: 8049643 [No Abstract] [Full Text] [Related]
8. Tamoxifen to prevent breast cancer. Morrow M; Jordan VC Adv Surg; 2000; 34():287-99. PubMed ID: 10997224 [No Abstract] [Full Text] [Related]
9. Tamoxifen for the prevention of breast cancer: yes. Vogel VG; Saenz M Important Adv Oncol; 1995; ():187-200. PubMed ID: 7672805 [No Abstract] [Full Text] [Related]
12. Another view of tamoxifen. Napoli M Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681 [No Abstract] [Full Text] [Related]
13. Tamoxifen and secondary tumours. An update. Wilking N; Isaksson E; von Schoultz E Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue. Bruzzi P BMJ; 1998 Apr; 316(7139):1181-2. PubMed ID: 9552991 [No Abstract] [Full Text] [Related]
15. Tamoxifen and breast cancer--from palliation to prevention. Rich SE Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194 [TBL] [Abstract][Full Text] [Related]
16. Confusion reigns over breast cancer. Birmingham K Nat Med; 2001 Dec; 7(12):1266. PubMed ID: 11726953 [No Abstract] [Full Text] [Related]
17. Tamoxifen and breast cancer prevention: what should you tell your patients? Goel V CMAJ; 1998 Jun; 158(12):1615-7. PubMed ID: 9645176 [No Abstract] [Full Text] [Related]
18. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Jordan VC Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908 [No Abstract] [Full Text] [Related]
19. The National Surgical Adjuvant Breast Project (NSABP) Breast Cancer Prevention Trial revisited. Love RR Cancer Epidemiol Biomarkers Prev; 1993; 2(5):403-7. PubMed ID: 8220082 [No Abstract] [Full Text] [Related]
20. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint. Fabian C Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909 [No Abstract] [Full Text] [Related] [Next] [New Search]